Latest News for Genfit Stock (NASDAQ:GNFT)

Tuesday, November 14, 2023

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights - Nov 14, 2023, 8:06AM

Tuesday, September 26, 2023

GENFIT Announces Publication In Nature Medicine Confirming The Performance Of Its Nash Diagnostic Technology
Benzinga Newsdesk - Sep 26, 2023, 4:24PM

Thursday, September 21, 2023

HC Wainwright & Co. Reiterates Buy on Genfit, Maintains $11 Price Target
Benzinga Newsdesk - Sep 21, 2023, 6:32AM

Wednesday, September 20, 2023

Genfit H1 EPS $(0.4578) Down From $(0.23) YoY, Sales $16.76M Up From $9.62M YoY
Happy Mohamed - Sep 20, 2023, 4:24PM

Thursday, July 13, 2023

Intercept Pharma Gets Double Upgrade: Analyst Says OCA Combo Therapy Can Extend PBC Business
Vandana Singh - Jul 13, 2023, 2:36PM

Monday, July 03, 2023

Analyst Expectations for Genfit's Future
Benzinga Insights - Jul 3, 2023, 10:00AM
HC Wainwright & Co. Maintains Buy on Genfit, Raises Price Target to $11
Benzinga Newsdesk - Jul 3, 2023, 9:03AM

Friday, June 30, 2023

Genfit's Miss Is CymaBay Therapeutics' Gain: Analyst Says Rival Data Leaves Room for Seladelpar To Emerge As Best-In-Class
Vandana Singh - Jun 30, 2023, 2:51PM
Ipsen, Genfit's Elafibranor Shows Promise In Primary Biliary Cholangitis Patients
Vandana Singh - Jun 30, 2023, 2:03PM
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights - Jun 30, 2023, 1:37PM
Why Renalytix Are Trading Higher By Over 48%; Here Are 20 Stocks Moving Premarket
Lisa Levin - Jun 30, 2023, 8:12AM
Genfit shares are trading higher after the company with its partner Ipsen said ELATIVE Phase 3 trial of elafibranor for primary biliary cholangitis met its primary endpoint.
Benzinga Newsdesk - Jun 30, 2023, 6:34AM
Ipsen And Genfit Announced Topline Data From The Pivotal ELATIVE Phase 3 Trial, Of Elafibrano For Primary Biliary Cholangitis; The Trial Met Its Primary Composite Endpoint, With 51% Of Patients Achieving Cholestasis Response Compared With 4% On Placebo
Benzinga Newsdesk - Jun 30, 2023, 6:18AM

Thursday, June 22, 2023

12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights - Jun 22, 2023, 9:12AM

Thursday, June 01, 2023

HC Wainwright & Co. Reiterates Buy on Genfit, Maintains $9 Price Target
Benzinga Newsdesk - Jun 1, 2023, 7:28AM

Wednesday, May 24, 2023

HC Wainwright & Co. Reiterates Buy on Genfit, Maintains $9 Price Target
Benzinga Newsdesk - May 24, 2023, 6:35AM

Monday, May 22, 2023

What Now After FDA AdComm Rebuke for Intercept Pharmaceutical? Analyst Says Approval Of Intercept's 'OCA In NASH May Never Occur
Vandana Singh - May 22, 2023, 4:20PM

Monday, April 17, 2023

HC Wainwright & Co. Maintains Buy on Genfit, Raises Price Target to $9
Benzinga Newsdesk - Apr 17, 2023, 6:16AM

Thursday, April 13, 2023

Genfit FY EPS $(0.53) Down From $1.46 YoY
Michael Horton - Apr 13, 2023, 4:13PM
Earnings Scheduled For April 13, 2023
Benzinga Insights - Apr 13, 2023, 4:42AM

Monday, October 10, 2022

12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights - Oct 10, 2022, 8:10AM

Wednesday, September 28, 2022

GENFIT Reports H1 2022 Revenues And Other Income Of €3.43M Down From €12.2M YoY
Benzinga Newsdesk - Sep 28, 2022, 4:11PM
Earnings Scheduled For September 28, 2022
Benzinga Insights - Sep 28, 2022, 4:28AM

Thursday, September 22, 2022

12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights - Sep 22, 2022, 5:35PM

Monday, September 19, 2022

Genfit To Buy This Swiss Firm Expanding Its Portfolio in Liver Diseases
Vandana Singh - Sep 19, 2022, 12:42PM

Wednesday, September 14, 2022

US Stock Futures Rise After Recording Worst Sell-Off Since June 2020; PPI Data In Focus
Lisa Levin - Sep 14, 2022, 5:57AM
BRP, Conformis And 3 Stocks To Watch Heading Into Wednesday
Lisa Levin - Sep 14, 2022, 5:19AM

Tuesday, September 13, 2022

Important Biotech Catalysts For September 13, 2022 - End Of The Day Summary
Ragothaman Srinivasan - Sep 13, 2022, 6:45PM
GENFIT Gets FDA Orphan Drug Status For Liver Disease Candidate
Ragothaman Srinivasan - Sep 13, 2022, 5:18PM
GENFIT Announces FDA Has Granted Orphan Drug Designation To GNS5611, For The Treatment Of Cholangiocarcinoma
Benzinga Newsdesk - Sep 13, 2022, 4:12PM

Friday, August 19, 2022

Analyzing Genfit's Short Interest
Benzinga Insights - Aug 19, 2022, 1:03PM

Monday, July 11, 2022

12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights - Jul 11, 2022, 2:37PM

Tuesday, June 07, 2022

38 Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin - Jun 7, 2022, 12:01PM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights - Jun 7, 2022, 8:13AM

Monday, April 25, 2022

56 Biggest Movers From Friday
Lisa Levin - Apr 25, 2022, 4:23AM

Friday, April 22, 2022

35 Stocks Moving In Friday's Mid-Day Session
Lisa Levin - Apr 22, 2022, 12:25PM
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights - Apr 22, 2022, 9:11AM
22 Stocks Moving in Friday's Pre-Market Session
Lisa Levin - Apr 22, 2022, 5:56AM

Monday, April 11, 2022

SVB Leerink Maintains Outperform on Genfit, Lowers Price Target to $10
Benzinga Newsdesk - Apr 11, 2022, 4:42AM

Thursday, April 07, 2022

Genfit FY21 EPS €1.23 vs €0.00 In FY20, Sales €85.579M vs €7.758M In FY20
Benzinga Newsdesk - Apr 7, 2022, 4:12PM
Earnings Scheduled For April 7, 2022
Benzinga Insights - Apr 7, 2022, 4:39AM

Wednesday, March 02, 2022

12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights - Mar 2, 2022, 4:31PM

Tuesday, January 18, 2022

12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights - Jan 18, 2022, 5:54PM

Wednesday, December 29, 2021

21 Stocks Moving in Wednesday's Pre-Market Session
Lisa Levin - Dec 29, 2021, 6:40AM

Tuesday, December 28, 2021

12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights - Dec 28, 2021, 4:34PM
51 Biggest Movers From Yesterday
Lisa Levin - Dec 28, 2021, 4:23AM

Monday, December 27, 2021

34 Stocks Moving In Monday's Mid-Day Session
Lisa Levin - Dec 27, 2021, 12:01PM
15 Stocks Moving in Monday's Pre-Market Session
Lisa Levin - Dec 27, 2021, 6:17AM

Thursday, December 23, 2021

12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights - Dec 23, 2021, 8:24AM

Wednesday, December 22, 2021

12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights - Dec 22, 2021, 4:32PM

Open3.210	Close3.265
Vol / Avg.1.422K / 22.978K	Mkt Cap161.964M
Day Range3.130 - 3.265	52 Wk Range2.894 - 4.750

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Latest News for Genfit Stock (NASDAQ:GNFT)

Tuesday, November 14, 2023

Tuesday, September 26, 2023

Thursday, September 21, 2023

Wednesday, September 20, 2023

Thursday, July 13, 2023

Monday, July 03, 2023

Friday, June 30, 2023

Thursday, June 22, 2023

Thursday, June 01, 2023

Wednesday, May 24, 2023

Monday, May 22, 2023

Monday, April 17, 2023

Thursday, April 13, 2023

Monday, October 10, 2022

Wednesday, September 28, 2022

Thursday, September 22, 2022

Monday, September 19, 2022

Wednesday, September 14, 2022

Tuesday, September 13, 2022

Friday, August 19, 2022

Monday, July 11, 2022

Tuesday, June 07, 2022

Monday, April 25, 2022

Friday, April 22, 2022

Monday, April 11, 2022

Thursday, April 07, 2022

Wednesday, March 02, 2022

Tuesday, January 18, 2022

Wednesday, December 29, 2021

Tuesday, December 28, 2021

Monday, December 27, 2021

Thursday, December 23, 2021

Wednesday, December 22, 2021